During the analysis of the sample, specific attention was paid during WES to the genes associated with multiple endocrine neoplasia (CDKN1B, RET, MEN1) and TSC genes, but no variants clinically relevant to the described phenotype of the patient were observed. This evidence concerns the gene TSC1 and multiple endocrine neoplasia.